Maribavir use in patients with renal impairment
TRANSPLANT INFECTIOUS DISEASE(2023)
Abstract
AK has nothing to disclose. NN has nothing to disclose. MA has nothing to disclose. Data from Takeda Pharmaceuticals U.S.A. Inc. was provided by the company upon specific request from the authors for data on maribavir and renal impairment. Takeda Pharmaceuticals U.S.A. Inc. was not involved in any aspects of manuscript conception or preparation. The data that supports the findings of this paper is available from the corresponding author, AK, upon reasonable request.
MoreTranslated text
Key words
Cytomegalovirus,Maribavir,Renal Impairment,Kidney Impairment
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined